Rong Fan from Sunnyvale, CA, age 56

Rong Fan

view source

Specialties:

Anatomic Pathology & Clinical Pathology

Work:

IU Health Pathology Laboratory
350 W 11 St RM 4010, Indianapolis, IN 46202
3174916000 (phone), 3174916419 (fax)

Education:

Medical School
Beijing Med Univ, Beijing City, Beijing, China
Graduated: 1991

Languages:

English

Description:

Dr. Fan graduated from the Beijing Med Univ, Beijing City, Beijing, China in 1991. He works in Indianapolis, IN and specializes in Anatomic Pathology & Clinical Pathology. Dr. Fan is affiliated with Indiana University Health Methodist Hospital, IU Health University Hospital and Riley Hospital For Children At Indiana University Health.

Dr. At Caltech

view source

Position:

Dr. at caltech

Location:

Greater Los Angeles Area

Industry:

Research

Work:

caltech
Dr.

Education:

University of California, Berkeley 2001 - 2006

Designer/Planner At Humphreys And Partners Architects

view source

Position:

Designer/Planner at Humphreys and Partners Architects

Location:

Orange County, California Area

Industry:

Architecture & Planning

Work:

Humphreys and Partners Architects
Designer/Planner

Education:

University of Southern California 2002 - 2004
Master, Real Estate Development

Software Engineer

view source

Position:

Software Engineer at Assurant Solutions

Location:

Miami, Florida

Industry:

Telecommunications

Work:

Assurant Solutions - Assurant since Jul 2011
Software Engineer

Rong Fan

view source

Location:

United States

Software Developer At Parasoft

view source

Location:

Greater Los Angeles Area

Industry:

Computer Software

Us Patents

Pcan065 Antibody Compositions And Methods Of Use
view source
US Patent:

8173434, May 8, 2012
Filed:

Oct 14, 2010
Appl. No.:

12/904709
Inventors:

Rong A. Fan - Redwood City CA, US
Kirstin L. Krall - San Jose CA, US
Assignee:

Diadexus, Inc. - South San Francisco CA
International Classification:

G01N 33/48
US Classification:

436 64
Abstract:

The invention provides isolated anti-PCan065 antibodies that bind to PCan065. The invention also encompasses compositions comprising an anti-PCan065 antibody and a carrier. These compositions can be provided in an article of manufacture or a kit. Another aspect of the invention is an isolated nucleic acid encoding an anti-PCan065 antibody, as well as an expression vector comprising the isolated nucleic acid. Also provided are cells that produce the anti-PCan065 antibodies. The invention encompasses a method of producing the anti-PCan065 antibodies. Other aspects of the invention are a method of killing an PCan065-expressing cancer cell, comprising contacting the cancer cell with an anti-PCan065 antibody and a method of alleviating or treating an PCan065-expressing cancer in a mammal, comprising administering a therapeutically effective amount of the anti-PCan065 antibody to the mammal.

Methods And Systems For Detecting And/Or Sorting Targets
view source
US Patent:

8354231, Jan 15, 2013
Filed:

Jan 4, 2010
Appl. No.:

12/652000
Inventors:

Gabriel A. Kwong - Alhambra CA, US
Ryan C. Bailey - Urbana IL, US
Rong Fan - Pasadena CA, US
James R. Heath - South Pasadena CA, US
Assignee:

Cal. Inst. Tech. - Pasadena CA
International Classification:

C12Q 1/68
G01N 33/53
US Classification:

435 612, 435 71, 4352872, 4352883
Abstract:

Provided herein are methods and systems for detecting and/or sorting targets in a sample based on the combined use of polynucleotide-encoded protein and substrate polynucleotides. The polynucleotide-encoded protein is comprised of a protein that specifically binds to a predetermined target and of an encoding polynucleotide that specifically binds to a substrate polynucleotide, wherein the substrate polynucleotide is attached to a substrate.

Pcan065 Antibody Compositions And Methods Of Use
view source
US Patent:

20070237713, Oct 11, 2007
Filed:

Apr 4, 2007
Appl. No.:

11/696442
Inventors:

Rong Fan - Redwood City CA, US
Kirstin Krall - San Jose CA, US
International Classification:

A61K 51/00
A61K 39/395
C12N 5/06
C07K 16/46
C07K 16/30
US Classification:

424001490, 424155100, 424178100, 530388800, 530391100, 435326000, 435338000
Abstract:

The invention provides isolated anti-PCan065 antibodies that bind to PCan065. The invention also encompasses compositions comprising an anti-PCan065 antibody and a carrier. These compositions can be provided in an article of manufacture or a kit. Another aspect of the invention is an isolated nucleic acid encoding an anti-PCan065 antibody, as well as an expression vector comprising the isolated nucleic acid. Also provided are cells that produce the anti-PCan065 antibodies. The invention encompasses a method of producing the anti-PCan065 antibodies. Other aspects of the invention are a method of killing an PCan065-expressing cancer cell, comprising contacting the cancer cell with an anti-PCan065 antibody and a method of alleviating or treating an PCan065-expressing cancer in a mammal, comprising administering a therapeutically effective amount of the anti-PCan065 antibody to the mammal.

Lng105 Antibody Composition And Methods Of Use, And Use Of Lng105 To Assess Lung Cancer Risk
view source
US Patent:

20070292346, Dec 20, 2007
Filed:

Mar 25, 2005
Appl. No.:

10/593799
Inventors:

Rong Fan - Redwood City CA, US
Nam Kim - Santa Clara CA, US
Robert Wolfert - Palo Alto CA, US
Glenn Pilkington - Victoria, AU
International Classification:

A61K 51/10
A61K 39/395
A61P 35/00
C07K 16/30
C12N 5/22
G01N 33/566
G01N 33/574
C12P 21/04
C12N 5/12
C07K 16/18
A61K 49/00
US Classification:

424001490, 424155100, 424009100, 435325000, 435007230, 435070210, 436501000, 530387300, 530388800
Abstract:

This invention relates to a method for assessing risk of lung and/or breast cancer. Specifically, in one embodiment it relates to utilizing Lng105 to determine the risk of lung cancer. Specific antibodies are disclosed.

Methods And Systems For Detecting And/Or Sorting Targets
view source
US Patent:

20090017455, Jan 15, 2009
Filed:

Aug 1, 2007
Appl. No.:

11/888502
Inventors:

Gabriel A. Kwong - Alhambra CA, US
Ryan C. Bailey - Urbana IL, US
Rong Fan - Pasadena CA, US
James R. Heath - South Pasadena CA, US
International Classification:

C12Q 1/68
US Classification:

435 6
Abstract:

Provided herein are methods and systems for detecting and/or sorting targets in a sample based on the combined use of polynucleotide-encoded-protein and substrate polynucleotides. The polynucleotide-encoded protein is comprised of a protein that specifically binds to a predetermined target and of an encoding polynucleotide that specifically binds to a substrate polynucleotide, wherein the substrate polynucleotide is attached to a substrate.

Arrays, Substrates, Devices, Methods And Systems For Detecting Target Molecules
view source
US Patent:

20090036324, Feb 5, 2009
Filed:

Jul 16, 2008
Appl. No.:

12/174601
Inventors:

Rong Fan - Pasadena CA, US
Habib Ahmad - Los Angeles CA, US
James R. Heath - South Pasadena CA, US
International Classification:

C40B 30/04
C40B 40/00
C40B 40/06
C40B 50/14
C40B 60/14
C40B 40/08
C40B 60/12
US Classification:

506 9, 506 13, 506 16, 506 17, 506 39, 506 30, 506 40
Abstract:

Arrays and substrates comprising a material, in particular capture agents and/or detectable targets, attached to the substrates along substantially parallel lines forming a barcoded pattern and related methods and systems.

Cln248 Antibody Compositions And Methods Of Use
view source
US Patent:

20090269345, Oct 29, 2009
Filed:

Dec 22, 2006
Appl. No.:

12/158729
Inventors:

Rong Fan - Redwood City CA, US
Nam Kim - Santa Clara CA, US
Robert L. Wolfert - Palo Alto CA, US
International Classification:

A61K 39/395
C07K 16/00
C12N 9/96
C12N 5/16
C12N 5/02
A61K 39/00
G01N 33/53
G01N 33/566
US Classification:

4241381, 5303871, 5303873, 5303881, 5303879, 5303911, 5303917, 435188, 435326, 4241301, 435375, 4241781, 435 71, 436501
Abstract:

Isolated anti-Cln248 antibodies that bind to Cln248 and cells that produce the anti-Cln248 antibodies are provided. Also provided are compositions of an anti-Cln248 antibody and a carrier. In addition, isolated nucleic acids encoding an anti-Cln248 antibody, as well as an expression vector for the isolated nucleic acids are provided. Methods for identifying anti-Cln248 antibodies, methods for producing the anti-Cln248 antibodies, as well as methods for their use in killing a Cln248-expressing cancer cells and alleviating or treating a Cln248-expressing cancer in a mammal are also provided.

Pcan065 Antibody Compositions And Methods Of Use
view source
US Patent:

20130224776, Aug 29, 2013
Filed:

May 8, 2012
Appl. No.:

13/466727
Inventors:

RONG A. FAN - REDWOOD CITY CA, US
KIRSTIN L. KRALL - SAN JOSE CA, US
Assignee:

DIADEXUS, INC. - SOUTH SAN FRANCISCO CA
International Classification:

G01N 33/574
US Classification:

435 794, 5303897, 53038885, 5303873, 5303913, 435188
Abstract:

The invention provides isolated anti-PCan065 antibodies that bind to PCan065. The invention also encompasses compositions comprising an anti-PCan065 antibody and a carrier. These compositions can be provided in an article of manufacture or a kit. Another aspect of the invention is an isolated nucleic acid encoding an anti-PCan065 antibody, as well as an expression vector comprising the isolated nucleic acid. Also provided are cells that produce the anti-PCan065 antibodies. The invention encompasses a method of producing the anti-PCan065 antibodies. Other aspects of the invention are a method of killing an PCan065-expressing cancer cell, comprising contacting the cancer cell with an anti-PCan065 antibody and a method of alleviating or treating an PCan065-expressing cancer in a mammal, comprising administering a therapeutically effective amount of the anti-PCan065 antibody to the mammal.